Dror Ortho-Design, Inc. financial data

Symbol
DROR on OTC
Location
480 Johnson Road, Suite 200, Washington, PA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 51.7 % -92.3%
Debt-to-equity -197 % -1220%
Return On Equity 666 %
Return On Assets -686 % -272%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 957M shares +93.2%
Common Stock, Shares, Outstanding 957M shares +93.2%
Entity Public Float 4.31M USD 0%
Common Stock, Value, Issued 95.7K USD +93.2%
Weighted Average Number of Shares Outstanding, Basic 957M shares +93.2%
Weighted Average Number of Shares Outstanding, Diluted 957M shares +93.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 1.34M USD -3.32%
General and Administrative Expense 1.42M USD -2.71%
Operating Income (Loss) -3.74M USD +41.6%
Nonoperating Income (Expense) -27.8K USD -182%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.3M USD +23.7%
Net Income (Loss) Attributable to Parent -4.3M USD +23.7%
Earnings Per Share, Basic 0 USD/shares 0%
Earnings Per Share, Diluted 0 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.83M USD +6640%
Other Assets, Current 1.26K USD -77.1%
Assets, Current 111K USD -94.1%
Property, Plant and Equipment, Net 21.7K USD -18.5%
Assets 133K USD -93.1%
Accounts Payable, Current 406K USD +330%
Accrued Liabilities, Current 592 USD +0.34%
Liabilities, Current 1.64M USD +536%
Other Liabilities, Noncurrent 158K USD
Liabilities 1.8M USD +583%
Retained Earnings (Accumulated Deficit) -20.8M USD -26%
Stockholders' Equity Attributable to Parent -1.66M USD -200%
Liabilities and Equity 133K USD -93.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -500K USD +36%
Net Cash Provided by (Used in) Financing Activities 300K USD
Net Cash Provided by (Used in) Investing Activities -16.7K USD
Common Stock, Shares Authorized 3.25B shares 0%
Common Stock, Shares, Issued 957M shares +93.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -200K USD +75%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 64.5K USD -96.5%
Deferred Tax Assets, Valuation Allowance 11.3M USD +13.8%
Deferred Tax Assets, Gross 11.3M USD +13.8%
Depreciation 1.24K USD +165%
Payments to Acquire Property, Plant, and Equipment 16.7K USD
Deferred Tax Assets, Operating Loss Carryforwards 9.88M USD +6.96%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 12.5M shares 0%
Unrecognized Tax Benefits 2.05M USD
Additional Paid in Capital 19.1M USD +5.11%
Preferred Stock, Shares Outstanding 5.85M shares -44.1%
Deferred Tax Assets, Net of Valuation Allowance 9.95M USD +374%
Share-based Payment Arrangement, Expense 2.25M USD -0.34%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%